May 9, 2023 (v1)
Publication
Resistance mechanisms to immune checkpoint inhibitors (ICI) in cancer patients are not fully understood and predictive biomarkers are lacking. TNF is a pleiotropic cytokine that can be detrimental in cancer and TNF blockade potentiates ICI efficacy in preclinical models. MELANFα (NCT03348891) is a translational proof-of-concept, open-label,...
Uploaded on: April 5, 2025